Memorial Sloan Kettering Cancer Center - Main Campus — Ney York, New York

Memorial Sloan Kettering Cancer Center - Main Campus is a clinical research site located in Ney York, New York, United States 10065.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center - Main Campus has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Sponsors: Philogen S.p.A..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ney York

Browse all research sites in New York · View every site in Ney York

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center - Main Campus?

Memorial Sloan Kettering Cancer Center - Main Campus has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center - Main Campus conducted?

Memorial Sloan Kettering Cancer Center - Main Campus has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Is Memorial Sloan Kettering Cancer Center - Main Campus accredited by Crixeo Clinical Trials?

Memorial Sloan Kettering Cancer Center - Main Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center - Main Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.